BIO-BRIDGE SCIENCE (BGES.OB)
-OTC BB | Prev Close: | 0.52 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.37 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.51 - 0.75 |
|---|
| Volume: | N/A |
|---|
| Avg Vol (3m): | 169 |
|---|
| Market Cap: | 23.99M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.06 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
- BIO BRIDGE SCIENCE INC FinancialsEDGAR Online Financials(Sat, Nov 26)
- BIO BRIDGE SCIENCE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Nov 21)
- BIO BRIDGE SCIENCE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Aug 15)
- BIO BRIDGE SCIENCE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Aug 15)
- BIO BRIDGE SCIENCE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 23)
- BIO BRIDGE SCIENCE INC Files SEC form 10-K, Annual ReportEDGAR Online(Fri, Apr 15)
- BIO BRIDGE SCIENCE INC FinancialsEDGAR Online Financials(Tue, Mar 1)
Financial Blogs
- No Financial Blogs available for BGES.OB at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 315.86 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Bio-Bridge Science Inc., a biotechnology company, focuses on the commercial development of vaccines for the prevention and treatment of human immunodeficiency virus (HIV) diseases.
View More